Andy Minn
University of Pennsylvania
H-index: 51
North America-United States
Top articles of Andy Minn
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
p53 promotes revival stem cells in the regenerating intestine after severe radiation injury | Nature Communications | Clara Morral Arshad Ayyaz Hsuan-Cheng Kuo Mardi Fink Ioannis I Verginadis | 2024/4/8 |
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer | Cancer Cell | Danish Memon Adam J Schoenfeld Darwin Ye George Fromm Hira Rizvi | 2024/2/12 |
Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction | Nature cancer | Jingya Qiu Bihui Xu Darwin Ye Diqiu Ren Shangshang Wang | 2023/1 |
RUNX1 is required in granulocyte–monocyte progenitors to attenuate inflammatory cytokine production by neutrophils | Genes & Development | Alexandra U Zezulin Daniel Yen Darwin Ye Elizabeth D Howell Erica Bresciani | 2023/7/1 |
Signal recovery in single cell batch integration | bioRxiv | Zhaojun Zhang Divij Mathew Tristan Lim Kaishu Mason Clara Morral Martinez | 2023/5/8 |
TLR priming licenses NAIP inflammasome activation by immunoevasive ligands | bioRxiv | James P Grayczyk Marisa S Egan Luying Liu Emily Aunins Meghan A Wynosky-Dolfi | 2023/5/4 |
Genome-Scale CRISPR-Cas12a Screen Identifies Novel Fetal Hemoglobin Regulators | Blood | Elizabeth A Traxler Chad Komar Megan Saari A Josephine Thrasher Kunhua Qin | 2023/11/28 |
Immunomodulatory RNA | 2023/4/20 | ||
579-C Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade | Kevin Wang Paulina Coutifaris David Brocks Sabrina Solis Nicholas Han | 2023/11/1 | |
A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma. | Timothy J Brown Andy J Minn Erica L Carpenter Edgar Ben-Josef Thomas Benjamin Karasic | 2023/2/1 | |
Isolation of Epithelial and Stromal Cells from Colon Tissues in Homeostasis and Under Inflammatory Conditions | Bio-protocol | K. E. Morral C. Ghinnagow R. Karakasheva | 2023/9 |
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors | Nature cancer | Hongru Zhang Pengfei Yu Vivek S Tomar Xiangjie Chen Matthew J Atherton | 2022/7 |
Single-cell RNA sequencing analysis and transgenic mouse models reveal differential effects of flash vs. standard proton radiotherapy on gastrointestinal tissues and tumors | Cancer Research | Ioannis I Verginadis Clara Morral Martinez Tristan Lim Priyanka Chowdhury Giorgos Skoufos | 2022/6/15 |
Radiotherapy with durvalumab vs. cetuximab in patients with locoregionally advanced head and neck cancer and a contraindication to cisplatin: phase II results of NRG-HN004 | International Journal of Radiation Oncology, Biology, Physics | LK Mell P Torres-Saavedra S Wong S Chang JA Kish | 2022/12/1 |
Administration of anti-CD40 enhances local and systemic antitumor efficacy of radiotherapy in allograft tumor model of a check-point blockade resistant melanoma | Cancer Research | Sanjay Pandey Claudia G Chavez Indranil Basu Andy Minn Chandan Guha | 2022/6/15 |
Durable response and improved CD8 T cell plasticity in lung cancer patients after PD1 blockade and JAK inhibition | medRxiv | Divij Mathew Melina E Marmarelis Caitlin Foley Joshua M Bauml Darwin Ye | 2022/11/7 |
The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade | Immunity | Lisa Cucolo Qingzhou Chen Jingya Qiu Yongjun Yu Max Klapholz | 2022/4/12 |
644 Major pathologic response after a single radiotherapy fraction+ a single pembrolizumab dose given preoperatively in patients with cT1N0 triple negative breast cancer (TNBC … | Julia Tchou Amy Clark Neil Taunk Gary Freedman Nucleus Xu | 2022/11/1 | |
Therapeutic interruption of T cell development generates high-affinity T cells that escape exhaustion and improve cancer immunotherapy | bioRxiv | Erica Dhuey Olivia Oldridge Roshan Ravishankar Hannah Dada Yongjun Yu | 2022/1/21 |
P1. 15-07 Phase II Study of Pembrolizumab and Itacitinib for First Line Treatment of Metastatic NSCLC Expressing PD-L1 | Journal of Thoracic Oncology | ME Marmarelis D Mathew JM Bauml W-T Hwang J Zhang | 2022/9/1 |
